| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.630 | 1.654 | 1.473 | 756 | 50 | 221 | 55 | 284 | 257 | 460 |
| Total Income - EUR | 1.630 | 1.655 | 1.474 | 757 | 50 | 221 | 55 | 284 | 257 | 460 |
| Total Expenses - EUR | 165 | 117 | 148 | 109 | 280 | 97 | 176 | 195 | 161 | 198 |
| Gross Profit/Loss - EUR | 1.465 | 1.538 | 1.325 | 649 | -231 | 124 | -121 | 89 | 96 | 262 |
| Net Profit/Loss - EUR | 1.416 | 1.488 | 1.281 | 626 | -232 | 118 | -121 | 88 | 81 | 221 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oftadoc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.306 | 2.016 | 3.294 | 2.749 | 62 | 178 | 67 | 167 | 269 | 486 |
| Inventories | 0 | 0 | 0 | 171 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 108 | 100 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Cash | 2.198 | 1.916 | 3.294 | 2.578 | 62 | 178 | 67 | 167 | 269 | 484 |
| Shareholders Funds | 1.942 | 1.542 | 1.353 | 1.954 | -171 | -49 | -169 | -82 | -1 | 220 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 364 | 474 | 1.941 | 795 | 232 | 227 | 237 | 248 | 270 | 265 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftadoc S.r.l.